1. Home
  2. BNR vs PXS Comparison

BNR vs PXS Comparison

Compare BNR & PXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • PXS
  • Stock Information
  • Founded
  • BNR 2014
  • PXS 2015
  • Country
  • BNR China
  • PXS Greece
  • Employees
  • BNR N/A
  • PXS N/A
  • Industry
  • BNR Medical Specialities
  • PXS Marine Transportation
  • Sector
  • BNR Health Care
  • PXS Consumer Discretionary
  • Exchange
  • BNR Nasdaq
  • PXS Nasdaq
  • Market Cap
  • BNR 38.3M
  • PXS 29.7M
  • IPO Year
  • BNR 2020
  • PXS N/A
  • Fundamental
  • Price
  • BNR $4.93
  • PXS $2.98
  • Analyst Decision
  • BNR
  • PXS Strong Buy
  • Analyst Count
  • BNR 0
  • PXS 1
  • Target Price
  • BNR N/A
  • PXS $10.00
  • AVG Volume (30 Days)
  • BNR 20.1K
  • PXS 52.2K
  • Earning Date
  • BNR 08-21-2025
  • PXS 08-11-2025
  • Dividend Yield
  • BNR N/A
  • PXS N/A
  • EPS Growth
  • BNR N/A
  • PXS N/A
  • EPS
  • BNR N/A
  • PXS 0.63
  • Revenue
  • BNR $72,112,038.00
  • PXS $49,342,000.00
  • Revenue This Year
  • BNR $136.32
  • PXS N/A
  • Revenue Next Year
  • BNR N/A
  • PXS $31.36
  • P/E Ratio
  • BNR N/A
  • PXS $4.69
  • Revenue Growth
  • BNR 0.53
  • PXS 8.07
  • 52 Week Low
  • BNR $2.18
  • PXS $2.53
  • 52 Week High
  • BNR $7.90
  • PXS $5.53
  • Technical
  • Relative Strength Index (RSI)
  • BNR 76.57
  • PXS 55.24
  • Support Level
  • BNR $3.06
  • PXS $2.76
  • Resistance Level
  • BNR $4.96
  • PXS $2.93
  • Average True Range (ATR)
  • BNR 0.25
  • PXS 0.10
  • MACD
  • BNR 0.15
  • PXS 0.01
  • Stochastic Oscillator
  • BNR 98.16
  • PXS 77.22

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About PXS Pyxis Tankers Inc.

Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.

Share on Social Networks: